Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Mechatronic Bio-Design and Development of an Exoskeleton to Improve Egonomics and Reduce Occupational Risks in Operators
Sanchez, Bryan , Nacarino, Adrian , Salguero, Robert Castro , Rey, Josue Alata, Cornejo, José , Vargas, Mariela , Cornejo, Jorge , Cornejo, Jose , Vargas, Mariela , Cornejo, Jorge , Rey, Josue Alata, Palomares, Ricardo

2025 IEEE International Conference on Interdisciplinary Approaches in Technology and Management for Social Innovation (IATMSI) | May 9, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/iatmsi64286.2025.10985727 Get It

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Perez, Kimberly , Rivero, Jaydira Del , Kennedy, Erin B. , Basu, Sandip , Chauhan, Aman , Connolly, Heidi M. , Dasari, Arvind , Gangi, Alexandra , Clarke, Callisia N. , Hallet, Julie , Grady, Erin , Ivanidze, Jana , Mittra, Erik , White, Sarah B. , Raj, Nitya , Vijayvergia, Namrata , Lewis, Mark A. , Kunz, Pamela L. , Mailman, Josh , Arshad, Junaid , Singh, Simron , Chandrasekharan, Chandrika, Janson, Eva Tiensuu , Bergsland, Emily K. , Del Rivero, Jaydira , Dasari, Arvind N , Howe, James R , Grady, Erin , Ivanidze, Jana , Raj, Nitya , Vijayvergia, Namrata , Kunz, Pamela L , Mailman, Josh , Arshad, Junaid , Soares, Heloisa P , Singh, Simron , Soulen, Michael C , Halfdanarson, Thorvardur R , Strosberg, Jonathan R , Clarke, Callisia N , Howe, James R. , Chan, Jennifer Ai-wen , Soares, Heloisa P. , Hálfdánarson, Þorvarður R. , Strosberg, Jonathan

JCO Oncology Practice | May 9, 2025 | Volume: 22 | Issue: 1 | Pages: 19-35

10.1200/op-25-00133 | PMID 40344544 Get It

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in Appendix 1 and 2 (online only) for more. PURPOSE To develop a clinical practice guideline and recommendations for symptom management of patients with well-differentiated grade 1 to grade 3 metastatic gastroenteropancreatic neuroendocrine tumors. METHODS ASCO convened an Expert Panel to develop a clinical practice guideline by reviewing the literature for relevant guidelines, systematic reviews, randomized controlled trials (RCTs), and observational studies to develop recommendations for clinical practice. RESULTS The literature review identified eight guidelines, 19 systematic reviews, and three RCTs that informed the development of guideline recommendations. RECOMMENDATIONS Recommendations are included for carcinoid syndrome, carcinoid heart disease and carcinoid crisis, and functional pancreatic neuroendocrine tumor syndromes. Recommendations are provided for surgical management, liver-directed therapy, and systemic therapy options, as well as palliative care. Limited guidance is provided for sequencing of interventions. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .
Endovascular rodent model using tail access and ultrasound guidance
Ognard, Julien , Hajj, G El , Lortscher, Sarah, Bayraktar, Esref Alperen , Brinjikji, Waleed , Kadirvel, Ramanathan , Kallmes, David F. , El Hajj, Gerard , Bayraktar, Esref Alperen , Oliver, Alexander A , Brinjikji, Waleed , Kadirvel, Ram , Ognard, Julien , Ding, Yonghong

Journal of NeuroInterventional Surgery | May 9, 2025 | Volume: 18 | Issue: 5 | Pages: 1487-1487

10.1136/jnis-2025-023444 | PMID 40345800 Get It

We have developed a cost-effective method to study the fate of stents, particularly flow diverter stents placed in the abdominal aorta, in a rat model. This technique utilizes (caudal) tail artery access,1–5 thereby avoiding the need for surgical exposure of the femoral or carotid arteries and reducing procedural invasiveness,6 7 aligning with the principles of refinement and reduction in animal research.7 This approach may be particularly beneficial for studies requiring multiple or iterative vascular access. The use of ultrasound guidance further reduces costs and infrastructure requirements by eliminating the need for specialized angiography suites.8 This makes this technique accessible to a broader range of research settings, promoting wider adoption and collaboration in the field of endovascular research. A detailed demonstration of this method is provided in the accompanying educational video (video 1). Video 1 -Technical video describing the tail artery access and flow diverter deployment using ultrasound guidance.
An Intervention to Increase Advance Care Planning Among Older Adults With Advanced Cancer
Volandes, Angelo E., Chang, Yuchiao , Paasche‐Orlow, Michael K. , Lindvall, Charlotta , Zupanc, Seth N., Martins-Welch, Diana , Carney, Maria Torroella , Burns, Edith , Itty, Jennifer, Emmert-Tangredi, Kaitlin, Martin, Narda J., Sanghani, Shreya, Tilburt, Jon C. , Davis, Aretha Delight , Garde, Cynthia, El‐Jawahri, Areej , Quintiliani, Lisa M. , Sciacca, Kate, Tulsky, James A. , Lakin, Joshua R. , Zupanc, Sophia N. , Pollak, Kathryn I. , Barry, Michael J. , Goldman, Julie

JAMA Network Open | May 9, 2025 | Volume: 8 | Issue: 5 | Pages: e259150

10.1001/jamanetworkopen.2025.9150 | PMID 40343696 Get It

Importance Many older adults with advanced cancer never communicate goals of care or treatment preferences to their clinicians, raising the risk that care received will not match their values. Scalable models of care may help surmount this barrier. Objective To test whether a combined patient and clinician intervention increased the rate of advance care planning (ACP) documentation in large health care systems. Design, Setting, and Participants This stepped-wedge cluster randomized clinical trial using an open cohort design included patients aged 65 years or older with advanced cancer seen at oncology clinics in 3 health care systems located in the US South, Midwest, and Mid-Atlantic regions from April 1, 2020, to November 30, 2022. Data collection ended in 2024. Intervention The intervention involved delivering brief evidence-based patient-facing video decision aids available in 25 languages as well as goals-of-care communication training to oncology clinicians. Patients in the control period received usual care. Main Outcomes and Measures The primary outcome was ACP documentation, which included any electronic health record documentation of a goals-of-care conversation, palliative care, hospice, or limitation of life-sustaining treatments, identified via a validated natural language processing program. Analysis was performed on an intention-to-treat basis. Results Twenty-nine practices, comprising 13 800 unique eligible patients with a total of 29 357 repeated measurements, were included (mean [SD] age, 74.5 [6.6] years; 52.3% men [15 344 of 29 357 measurements]). The proportion of patients with ACP documentation was greater in the intervention phase compared with the usual care phase (adjusted rate difference, 6.8% [95% CI, 2.8%-10.8%]; P < .001). ACP documentation in the intervention phase occurred among 3980 of 15 754 patients (25.3%) (goals-of-care conversation, 21.4% [3377 of 15 754]; palliative care, 9.6% [1517 of 15 754]; hospice, 5.4% [847 of 15 754]; and limitation of life-sustaining treatments, 7.2% [1128 of 15 754]). In comparison, ACP documentation in the usual care phase occurred among 2834 of 13 603 patients (20.8%) (goals-of-care conversation, 16.8% [2281 of 13 603]; palliative care, 9.5% [1287 of 13 603]; hospice, 5.3% [724 of 13 603]; and limitation of life-sustaining treatments, 8.4% [1149 of 13 603]). Conclusions and Relevance In this stepped-wedge cluster randomized clinical trial for older adults with advanced cancer, a bundled evidence-based decision aid and communication training intervention increased the proportion of older patients with ACP documentation. This approach offers an innovative paradigm with a clinically meaningful increase in ACP documentation, a widely used quality metric that reflects high-quality patient-centered care delivery. Trial Registration ClinicalTrials.gov Identifier: NCT03609177
Spousal Support and Physician Work-Life Integration and Burnout
O’Sullivan, Ciara C. , Jenkins, Sarah M. , Ruddy, Kathryn J. , Marshall, Ariela L. , Leep Hunderfund, Andrea N, Marshall, Ariela , Hunderfund, Andrea N. Leep , West, Colin P.

JAMA Network Open | May 9, 2025 | Volume: 8 | Issue: 5 | Pages: e259507

10.1001/jamanetworkopen.2025.9507 | PMID 40343693 Get It

Importance Few studies have assessed whether factors outside the workplace, such as support from a spouse or partner, are associated with work-life integration (WLI) satisfaction and burnout among physicians. Evaluating such an association may help with developing novel strategies to address burnout and improve WLI satisfaction among this group. Objectives To compare spousal support among female and male physicians and explore associations of spousal support with WLI satisfaction and burnout. Design, Setting, and Participants This cross-sectional, multispecialty survey study was conducted among 661 faculty physicians employed at an academic medical center from March 26 to May 22, 2024. Main Outcomes and Measures Survey items measured spousal support (5 items), WLI satisfaction (1 item), and burnout (2 Maslach Burnout Inventory items). Associations of spousal support and gender with WLI and burnout were assessed using logistic regression analyses adjusting for age, race and ethnicity, weekly work hours, and weekly hours spent on household or childcare duties. Results Overall, 739 of 2103 faculty physicians (response rate, 35.1%) completed the survey, of whom 661 (89.4%) were currently married or partnered (359 of 661 men [54.3%]). In this subset, 322 of 351 male physicians (91.7%) and 276 of 298 of female physicians (92.6%) reported frequent career support (defined as often, most of the time, or always) over the last year from their spouse or partner. Physicians reporting high levels of career support from their spouse or partner had higher odds of WLI satisfaction (odds ratio [OR], 1.50 [95% CI, 1.22-1.86]; P < .001) and lower odds of burnout (OR, 0.73 [95% CI, 0.61-0.87]; P < .001), independent of gender and adjusted for age, race and ethnicity, weekly work hours, and weekly hours spent on household or childcare duties. Male physicians had higher odds of WLI satisfaction than female physicians (OR, 1.95 [95% CI, 1.32-2.90]; P < .001), even after adjusting for spousal career support and other covariates listed, whereas odds of burnout did not significantly differ by gender (OR, 0.84 [95% CI, 0.57-1.23]; P = .37). Conclusions and Relevance This study suggests that the level of career support from a spouse or partner is associated with WLI satisfaction and burnout among physicians, independent of gender. Future studies should explore whether interventions designed to enhance career support can improve WLI and well-being among physicians.
Editorial Comment: Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative Therapy
Henning, Grant , Henning, Grant M

JU Open Plus | May 9, 2025 | Volume: 3 | Issue: 5 | Pages: No page available

10.1097/ju9.0000000000000287 Get It

Clinical and pathological spectrum of disease severity among patients with acute liver failure (ALF) undergoing deceased donor liver transplantation
Tujios, Shannan R. , Sussman, Norman , Rakela, Jorge , Ganger, Daniel , Bass, Nathan M., Reuben, Adrian , Stravitz, R. Todd, Wang, Hanlin , Peng, Lan, Yeh, Matthew M., Hatfield, Bryce , Lee, William M. , Group, for the Acute Liver Failure Study, Rakela, Jorge L, Lee, William M , Rule, Jody A. , Kleiner, David Erwin , Choi, Eun-Young Karen , Yang, Guang‐Yu , Gill, Ryan M. , Fontana, Robert J. , Group, for the Acute Liver Failure Study

Liver Transplantation | May 9, 2025 | Volume: 31 | Issue: 11 | Pages: 1368-1378

10.1097/lvt.0000000000000634 | PMID 40341552 Get It

Listing and transplanting patients with acute liver failure (ALF) is challenging, requiring rapid assessment of the likelihood of recovery. The availability of a large number of ALF liver explants, along with their clinical data, afforded an opportunity to retrospectively evaluate liver transplantation (LT) decision-making. We hypothesized that, with the benefit of hindsight, a small number of patients might have recovered without LT. Three hundred liver explants from ALF patients of varying etiologies who had undergone LT over 22 years in the Acute Liver Failure Study Group registry were reviewed for histopathological features and degree of necrosis by a committee of 8 hepatopathologists. A second committee of 8 experienced transplant hepatologists independently reviewed clinical data on these same 300 patients and retrospectively scored the likelihood that each patient required transplantation. Only 3 (1%) of those reviewed by the Clinical Committee were considered to “Definitely” not require liver grafting, while an additional 10 (3.3%) were deemed to “Possibly” not require transplantation (Not Likely Group, N=13). There was no difference in the degree of necrosis in explants in these groups, when compared to the remaining Likely Group, N=287 (95.6%), except in acetaminophen (APAP)-associated ALF, where the degree of necrosis was more uniformly graded as severe, correlating with the need for transplantation. Virtually every patient undergoing LT for ALF retrospectively appeared to need their transplant, based on expert clinical consensus review. Overall, there was poor correlation between clinical severity and apparent degree of necrosis seen in the 300 liver explants, except perhaps for APAP subjects.
The Influence of Depressive and Manic Symptoms on Suicidal Ideation in Mixed Mood States
Macellaro, Monica , Kelly, Carlton Max, Lyu, Jihun , McElroy, Susan L., Nolen, Willem A., Keck, P E, Post, R M, Suppes, Trisha, Cafaro, Rita , Kelly, Carlton Max, Ostacher, Michael J. , Dell’Osso, Bernardo Maria , Frye, Mark A., Kupka, Ralph , McElroy, Susan L. , Post, Robert M. , Grunze, Heinz

No container title available | May 9, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6551903/v1 Get It

Abstract Background: While bipolar disorder is strongly linked to an increased risk of suicide, recent evidence has challenged the assumption that mixed symptoms play a distinct role in suicidal ideation beyond depressive severity. This study examines how depressive, hypo/manic, and mixed features influence suicidal ideation in individuals with bipolar disorder. Data from 903 participants in the Stanley Foundation Bipolar Network (1995–2002) were analyzed to assess associations between mood states, classified by the Inventory of Depressive Symptomatology–Clinician-Rated (IDS-C) and the Young Mania Rating Scale (YMRS), and suicidal ideation, measured using IDS-C item 18, using generalized estimating equations. Results: Depressive symptoms were strongly associated with suicidal ideation (OR = 21.98, 95% CI: 15.31–31.54). Moderate hypo/manic symptoms also conferred risk (OR = 3.11, 95% CI: 1.51–6.49), and milder hypo/mania showed a weaker but significant association (OR = 1.74, 95% CI: 1.05–2.89). The highest suicidal ideation was observed in individuals with hypo/mania featuring mixed symptoms (OR = 29.43), exceeding that of depression or depression with mixed features (OR = 21.98). However, findings diverged based on modeling approach: in continuous predictor models, SI was driven solely by depressive symptom severity, with no significant association observed for hypo/mania or its interaction with depression. In contrast, when mood states were categorized using clinically meaningful thresholds, hypo/mania with mixed features emerged as a distinct contributor to suicidal ideation risk. Conclusion: These findings underscore the need for integrating both dimensional and categorical approaches to mood state classification in research on suicidality in bipolar disorder.
Development of a Pentacistronic Ebola Virus Minigenome System
Zell, Brady N. , Swenson, Vaille A. , Wang, Lin , Barry, Michael A. , Yamaoka, Satoko , Lu, Shao‐Chia , Barry, Michael A , Zell, Brady , Ebihara, Hideki

Viruses | May 9, 2025 | Volume: 17 | Issue: 5 | Pages: 688

10.3390/v17050688 | PMID 40431699 Get It

Ebola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-adapted EBOV (MA-EBOV), we engineered novel pentacistronic minigenomes (5xMG) containing a reporter gene, VP40, and glycoprotein genes as well as the NP and VP24 genes from either EBOV or MA-EBOV. The 5xMGs were constructed and optimized, and the produced transcription- and replication-competent virus-like particles (trVLPs) were demonstrated to infect several cell lines. Introduction of the mouse-adaptation mutations did not significantly impact the replication and transcription of the 5xMG or the relative infectivity of the trVLPs in vitro. This work demonstrates the development of the 5xMG system as a new versatile tool to study EBOV biology.
Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study
Tang, Haiming , Xu, Jie , McCracken, Jenna , Li, Peng , Braunberger, Ryan C. , Wu, Xiaojun , Wang, Endi , Zhang, Qianyun , Soma, Lorinda, Zhang, Jingjing , Matsumoto, Nana , Xu, Mina L. , Pan, Zenggang , Tang, Haiming , Wang, Endi , Katz, Samuel G , Zhang, Jing Jing , Pan, Zenggang , Gisriel, Savanah D. , Ji, Yuan , Fang, Hong , Li, Shaoying , Xu‐Monette, Zijun Y. , Young, Ken H.

American Journal of Clinical Pathology | May 9, 2025 | Volume: 164 | Issue: 3 | Pages: 390-401

10.1093/ajcp/aqaf057 | PMID 40581918 Get It

Abstract Objective Rare large B-cell lymphomas (LBCLs) present with concurrent or subsequent lymphomatous effusion (solid-effusion LBCL, SE-LBCL), which may have an inferior prognosis compared with their noneffusion counterpart. In addition, the relationship between SE-LBCL and human herpesvirus 8–negative effusion-based LBCL (EB-LBCL) remains unclear. Methods We collected 141 cases of SE-LBCL and a control cohort of 101 cases of stage IV solid-only LBCL. The clinicopathologic features were analyzed and compared between SE-LBCL and solid-only LBCL. Results Patients with SE-LBCL had a median age of 67 years with a male-to-female ratio of 1.3:1. Eighty-six patients had concurrent solid lymphoma and lymphomatous effusion, whereas 55 developed lymphomatous effusion subsequently. Most cases involved the pleural cavities (79%, 112/141), followed by the peritoneal (21%, 29/141) and pericardial (11%, 16/141) cavities. BCL6, CD10, and MUM1 were expressed in 77% (90/117), 46% (60/130), and 61% (58/95) of cases, respectively, and 58% (71/123) were subclassified into the germinal center B-cell (GCB) subtype. Rearrangements of BCL2, BCL6, and MYC were detected in 42% (31/73), 35% (22/63), and 40% (35/88), respectively, and 22% (19/87) had both MYC and BCL2 rearrangements. The patients with SE-LBCL had a dismal prognosis, with a median survival of 5.7 months, which was significantly worse than solid-only LBCL (147.5 months; P < .0001). Conclusions The pathologic features of SE-LBCL were similar to those of solid-only LBCL but distinct from those of EB-LBCL; in particular, lymphomatous effusion was an independently adverse prognostic factor in LBCL. Our study underscores the need for surveillance of lymphomatous effusion during LBCL staging and development of effective therapeutic regimens for SE-LBCL.